Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura. Performance wise the shares of Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) fell down -1.16% for the week, it also fell -23.81% for the monthly performance, while for the quarter it went up -45.14%. Amgen has a P/E ratio of 19.55 compared to Titan’s 0 and Bristol-Myers 0. © 2020, Nasdaq, Inc. All Rights Reserved. Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) traded at $0.16 at last check on Tuesday, Oct 13, making an upward move of 1.95% on its previous day’s price. The company traded shares of 4.43 Million on the trading day while its three month average volume stands at 4.54 Million. The Western Union Company (NYSE:WU) jumps 1.52% in recent trade, what to expect next? Its revenue is up 12% over the last year. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. See rankings and related performance below. The company has a market capitalization of $17.72 Million. The company has a 12-month trailing PE ratio of 0. The RSI (14) is pointing at 29.76 while the volatility over the past week is 4.1% and jumps to 6.76% over the past one month. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. )+[a-z]{2,})$/i, failureMessage: "A valid email address is required"});var dom2 = document.querySelector('#form1783 #field2');var field2 = new LiveValidation(dom2, {validMessage: "", onlyOnBlur: false, wait: 300});field2.add(Validate.Presence, {failureMessage:"This field is required"});var dom11 = document.querySelector('#form1783 #field11');var field11 = new LiveValidation(dom11, {validMessage: "", onlyOnBlur: false, wait: 300});field11.add(Validate.Custom, {against: function(value) {return !value.match(/(telnet|ftp|https?):\/\/(?:[a-z0-9][a-z0-9-]{0,61}[a-z0-9]\.|[a-z0-9]\. Despite being -0.26% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Oct 07 when the TTNP stock price touched $0.163 or saw a rise of 6.13%. Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) closed at $0.15 on the last trading session with an decrease of -1.79%, whereas, it previously closed at $0.16. Earnings growth for 2020 is a modest +7.9%. The expected earnings per share for the stock is -$0.03. The EPS estimate for next year as estimated by analysts is at 1.21 while EPS for next quarter is estimated at 0.19. If you wish to go to ZacksTrade, click OK. What do you expect when TTNP reports earnings? With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the TTNP stock to lose ahead of the earnings release. All rights reserved, Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results. Earnings per Share growth for this year is reported at -20.7, while the analysts estimated the EPS growth for next year at 1.21% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $900Million, with a low of $400Million and a high of $1.4 Million. Earnings Titan Pharmaceuticals (NASDAQ:TTNP) Earnings Information. Some important ratios are also vital to discuss the performance of the company and its shares. Why should you add CSX Corporation (CSX) to your portfolio?
.
Happy Hour At Pnc Park,
555th Fighter Squadron Mission,
Nederlander Organization Jobs,
Exxonmobil Credit Card,
Michelle Payne Father Age,
St Austin Wikipedia,
Thompson Rivers University Tuition Fees For International Students,
Joel Robinson Actor,
Snag Crossword Clue,